Lluís Segú is Professor in the Master of Health Economics and Pharmacoeconomics at UPF-BSM.
He is BSc in Pharmacy from the University of Barcelona, Diploma in Health, International Public Health from Carlos III University of Madrid, and Master in Economic Evaluation and Management of Health Services from the University of Barcelona. Managing Partner of Oblikue Consulting SL, he is also Associate Professor of the Clinical Pharmacy Unit of the Department of Galenic Pharmacy and Pharmaceutical Technology of the Faculty of Pharmacy of the University of Barcelona, and Collaborator of the Center for Research in Economics and Health (CRES). He has held...
- Operations, Technology & Science
- Master Universitario, Social and Legal Sciences, Economics, management and health sciences
- Diploma, Social and Legal Sciences, Economics, management and health sciences
- Graduate, Science, Other
Professor
- Online Master in Health Economics and Pharmacoeconomics
- Online Master in Health Economics and Pharmacoeconomics
Actividad Investigadora y transferencia
- PUIG JUNOY, J., CAMPILLO ARTERO, C., SEGĂ TOLSA, J. L., TRAPERO BERTRAN, M. (2020). Price Models for Multi-indication Drugs: A Systematic Review. Applied Health Economics and Health Policy, Nueva Zelanda.
- CAMPILLO ARTERO, C., PUIG JUNOY, J., SEGĂ TOLSA, J. L., TRAPERO-BERTRAN, M. (2019). Price Models for Multi-indication Drugs: A Systematic Review. Applied Health Economics and Health Policy.
- COSTA, K. S., GOLDBAUM, M., GUAYTA-ESCOLIES, R., MODAMIO, P., MARIĂO, E. L., SEGĂ TOLSA, J. L. (2017). CoordinaciĂłn entre servicios farmacĂ©uticos para una farmacoterapia integrada: el caso de Cataluña. CiĂȘncia & SaĂșde Coectiva.
- LĂPEZ-MARTĂNEZ, N., SEGĂ TOLSA, J. L., VĂZQUEZ-CASTRO, J., BROSA, M., BOHIGAS, L., COMELLAS, M. J., KALFHAUS, L. (2017). Analysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support. Expert Review of Pharmacoeconomics & Outcomes Research.
- CLOPES, A., GASOL, M., CAJAL, R., SEGĂ TOLSA, J. L., CRESPO, R., MORA, R., ... GERMĂ, J. R. (2017). Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer. Journal of Medical Economics.
- SEGà TOLSA, J. L. (2016). ¿Qué servicios puede aportar la farmacia comunitaria al paciente crónico? Opinión de los profesionales. Pharmaceutical Care España, España.
- SEGĂ TOLSA, J. L. (2016). Acceso a los anticoagulantes de acciĂłn directa en España. Revista Española de CardiologĂa.